These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 4893969)

  • 1. [On the bactericidal properties of Dioxane with regard to the plague microbe].
    Maĭboroda GM; Rozhkov AA; Treshchilin PF; Masiukevich VN
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Apr; 43(4):121-5. PubMed ID: 4893969
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sensitivity of different strains of the causative agent of plague to disinfectants].
    Val'kov BG; Kostina GI; Saleeva VN; Agafonov AV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Jun; (6):71-4. PubMed ID: 463428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bactericidal action of formalin on the causative agent of plague].
    Malinina ZE; Isupov IV; Dudkova VK
    Arkh Patol; 1979; 41(5):80-2. PubMed ID: 378193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory diagnosis of plague.
    Rattan A; Kumar R
    Indian J Pediatr; 1994; 61(6):625-8. PubMed ID: 7721365
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative evaluation of effectivity of bacteriological examination and antibody neutralization reaction during the action of streptomycin on the plague microbe.
    Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(3):257-62. PubMed ID: 5529576
    [No Abstract]   [Full Text] [Related]  

  • 6. Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.
    Steinberger-Levy I; Zahavy E; Cohen S; Flashner Y; Mamroud E; Aftalion M; Gur D; Ber R
    Adv Exp Med Biol; 2007; 603():339-50. PubMed ID: 17966430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chromosomal resistance of plague agent to quinolones].
    Kasatkina IV; Shcherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1991 Aug; 36(8):35-7. PubMed ID: 1661573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibiotic effect on plague microbe antigens].
    Aparin GP
    Antibiotiki; 1973 Aug; 18(8):728-31. PubMed ID: 4776408
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of trimethoprim sensitivity in strains of Yersinia pestis isolated from various natural foci of plague].
    Kravchenko AN; Mishan'kin BN
    Antibiot Khimioter; 1989 Jan; 34(1):42-6. PubMed ID: 2730213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of the gel diffusion test in the differential diagnosis of the plague microbe].
    Timofeeva LA; Mironova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Jul; 43(7):145. PubMed ID: 4978066
    [No Abstract]   [Full Text] [Related]  

  • 11. Plague detection by anti-carbohydrate antibodies.
    Anish C; Guo X; Wahlbrink A; Seeberger PH
    Angew Chem Int Ed Engl; 2013 Sep; 52(36):9524-8. PubMed ID: 23843253
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania.
    Lyamuya EF; Nyanda P; Mohammedali H; Mhalu FS
    J Trop Med Hyg; 1992 Oct; 95(5):335-8. PubMed ID: 1404556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of Yersinia pestis to antimicrobial agents.
    Galimand M; Carniel E; Courvalin P
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3233-6. PubMed ID: 17005799
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibiotic sensitivity of plague microbe strains from foreign countries].
    Galenko GN; Akiev AK; Tarasova VE
    Antibiot Khimioter; 1992 Nov; 37(11):23-4. PubMed ID: 1300928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plague: Recognition, Treatment, and Prevention.
    Yang R
    J Clin Microbiol; 2018 Jan; 56(1):. PubMed ID: 29070654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of antibody neutralization reaction for diagnosis of plague under conditions of streptomycin therapy].
    Aparin GP
    Antibiotiki; 1970 Jul; 15(7):626-9. PubMed ID: 4920968
    [No Abstract]   [Full Text] [Related]  

  • 17. [The development of peroxosolvate-based composites and the evaluation of their effectiveness against extremely dangerous infective pathogens].
    Buianov VV; Nikol'skaia VP; Andrus VN; Pudova OB; Zharkova OA; Chmyr' IA; Elizarov VV
    Vestn Ross Akad Med Nauk; 2007; (12):34-7. PubMed ID: 18225504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Origin of the plague microbe Yersinia pestis: structure of the process of speciation].
    Suntsov VV
    Izv Akad Nauk Ser Biol; 2012; (1):5-13. PubMed ID: 22567866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotics of the aminoglycoside group (gentamicin, sisomicin and amikacin) in the prevention and treatment of experimental plague].
    Shcherbaniuk AI; Makarovskaia LN; Bugaeva OK; Kasatkina IV
    Antibiot Khimioter; 1992 May; 37(5):30-1. PubMed ID: 1417325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the antibody neutralization reaction in differential diagnosis of the etiologic agent of plague and the study of mutual relations between the amount of fraction I and virulence in strains of the plague microbe (Pasteurella pestis).
    Timofeeva LA; Aparin GP
    J Hyg Epidemiol Microbiol Immunol; 1968; 12(4):420-5. PubMed ID: 5752128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.